Skip to main content
SpringerLink
Log in

Klassifikation der Hodgkin-Lymphome und verwandter Entitäten

Neuigkeiten und offene Fragen

Classification of Hodgkin lymphoma and related entities

News and open questions

  • Schwerpunkt: Neue Klassifikationen in der Hämatopathologie
  • Published:
Die Pathologie Aims and scope Submit manuscript

Zusammenfassung

Vor kurzem sind 2 neue Lymphomklassifikationen, die 5. Edition der WHO-Klassifikation hämatolymphoider Tumoren und die „International Consensus Classification“ (ICC) des Clinical Advisory Committee, erschienen. Im Rahmen der Vorbereitung beider Klassifikationen wurden die bestehenden Lymphomentitäten erneut diskutiert und im Licht der in der letzten Zeit hinzugewonnenen klinischen, morphologischen und molekularen Daten reevaluiert. In diesem Review fassen wir die aktuelle Einordnung des klassischen und nodulären lymphozytenprädominanten Hodgkin-Lymphoms sowie die relevanten Differenzialdiagnosen zusammen.

Abstract

Two new classifications were recently released: the 5th edition of the WHO classification of hematolymphoid tumors and the International Consensus Classification (ICC) drafted by the Clinical Advisory Committee. In the preparation of both classifications, the previously existing lymphoma categories were reevaluated according to recently obtained data on clinical, morphological, and molecular findings. In this review we summarize the current placements of classic and nodular lymphocyte predominant Hodgkin lymphoma and their relevant differential diagnoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720–1748

    Article  PubMed  PubMed Central  Google Scholar 

  2. Asano N, Yamamoto K, Tamaru J et al (2009) Age-related Epstein-Barr virus (EBV)-associated B‑cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113:2629–2636

    Article  CAS  PubMed  Google Scholar 

  3. Bosch-Schips J, Granai M, Quintanilla-Martinez L et al (2022) The grey zones of classic hodgkin lymphoma. Cancers 14(3):742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229–1253

    Article  CAS  PubMed  Google Scholar 

  5. Chute DJ, Cousar JB, Mahadevan MS et al (2008) Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED‑2 primers. Diagn Mol Pathol 17:65–72

    Article  CAS  PubMed  Google Scholar 

  6. Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-positive lymphoproliferations of B‑ T‑ and NK-cell derivation in non-immunocompromised hosts. Pathogens 7:28

    Article  PubMed  PubMed Central  Google Scholar 

  7. Dojcinov SD, Venkataraman G, Pittaluga S et al (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726–4735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dojcinov SD, Venkataraman G, Raffeld M et al (2010) EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405–417

    Article  PubMed  PubMed Central  Google Scholar 

  9. Eberle FC, Rodriguez-Canales J, Wei L et al (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B‑cell lymphoma. Haematologica 96:558–566

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346–1356

    Article  PubMed  Google Scholar 

  11. Hartmann S, Doring C, Jakobus C et al (2013) Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma—endpoints of a spectrum of one disease? Plos One 8:e78812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hartmann S, Doring C, Vucic E et al (2015) Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol 169:415–422

    Article  PubMed  Google Scholar 

  13. Hartmann S, Eichenauer DA, Plutschow A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 122:4246–4252

    Article  CAS  PubMed  Google Scholar 

  14. Hartmann S, Goncharova O, Portyanko A et al (2019) CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma. Mod Pathol 32:37–47

    Article  CAS  PubMed  Google Scholar 

  15. Hartmann S, Plutschow A, Mottok A et al (2019) The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol. https://doi.org/10.1002/ajh.25607

    Article  PubMed  Google Scholar 

  16. Hartmann S, Schuhmacher B, Rausch T et al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30:844–853

    Article  CAS  PubMed  Google Scholar 

  17. Hartmann S, Soltani AS, Bankov K et al (2022) Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol 199:382–391

    Article  CAS  PubMed  Google Scholar 

  18. Hodgkin (1832) On some morbid appearances of the absorbent glands and spleen. Med Chir Trans 17:68–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Jackson H Jr., Parker F Jr. (1946) Hodgkin’s disease; clinical diagnosis. N Engl J Med 234:37–41

    Article  PubMed  Google Scholar 

  20. Jackson H Jr., Parker F Jr. (1946) Hodgkin’s disease; treatment and prognosis. N Engl J Med 234:103–110

    Article  PubMed  Google Scholar 

  21. Jaffe ES, Harris NL, Stein H et al (2001) WHO classification of tumors: pathology and genetics of tumors of Haematopoietic and lymphoid tissues. IARC Press, Lyon

    Google Scholar 

  22. Joos S, Granzow M, Holtgreve-Grez H et al (2003) Hodgkin’s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 103:489–495

    Article  CAS  PubMed  Google Scholar 

  23. Joos S, Menz CK, Wrobel G et al (2002) Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99:1381–1387

    Article  CAS  PubMed  Google Scholar 

  24. Küppers R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801–812

    Article  PubMed  Google Scholar 

  25. Küppers R, Rajewsky K, Zhao M et al (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962–10966

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lake A, Shield LA, Cordano P et al (2009) Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. Int J Cancer 125:1334–1342

    Article  CAS  PubMed  Google Scholar 

  27. Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26:1063–1083

    CAS  PubMed  Google Scholar 

  28. Nicolae A, Pittaluga S, Abdullah S et al (2015) EBV-positive large B‑cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Overkamp M, Quintanilla-Martinez L, Fend F (2022) EBV-associated lymphoproliferative disorders. Pathologie 43:282–291

    Article  PubMed  Google Scholar 

  30. Oyama T, Yamamoto K, Asano N et al (2007) Age-related EBV-associated B‑cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124–5132

    Article  CAS  PubMed  Google Scholar 

  31. Pittaluga S, Nicolae A, Wright GW et al (2020) Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B‑cell lymphoma and classical Hodgkin lymphoma. Blood Cancer Discov 1:155–161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Poppema S, Kaiserling E, Lennert K (1979) Hodgkin’s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres—a cytohistological study. Histopathology 3:295–308

    Article  CAS  PubMed  Google Scholar 

  33. Poppema S, Kaiserling E, Lennert K (1979) Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 31:211–225

    Article  CAS  PubMed  Google Scholar 

  34. Quintanilla-Martinez L, Fend F, Moguel LR et al (1999) Peripheral T‑cell lymphoma with Reed-Sternberg-like cells of B‑cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 23:1233–1240

    Article  CAS  PubMed  Google Scholar 

  35. Reichel J, Chadburn A, Rubinstein PG et al (2015) Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 125:1061–1072

    Article  CAS  PubMed  Google Scholar 

  36. Rudiger T, Jaffe ES, Delsol G et al (1998) Workshop report on Hodgkin’s disease and related diseases (’grey zone‘ lymphoma). Ann Oncol 9(Suppl 5):S31–S38

    Article  PubMed  Google Scholar 

  37. Sarkozy C, Hung SS, Chavez EA et al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765–1776

    Article  CAS  PubMed  Google Scholar 

  38. Schmitz R, Hansmann ML, Bohle V et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981–989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Schuhmacher B, Bein J, Rausch T et al (2019) JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T‑cell/histiocyte-rich large B‑cell lymphoma. Haematologica 104:330–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Shankar AG, Kirkwood AA, Hall GW et al (2015) Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma—A review of clinical outcome based on the histological variants. Br J Haematol 171(2):254–262. https://doi.org/10.1111/bjh.13540

    Article  CAS  PubMed  Google Scholar 

  41. Slack GW, Ferry JA, Hasserjian RP et al (2009) Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis. Leuk Lymphoma 50:937–943

    Article  CAS  PubMed  Google Scholar 

  42. Tiacci E, Ladewig E, Schiavoni G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood 131:2454–2465

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tousseyn TA, King RL, Fend F et al (2023) Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities. Virchows Arch 482:207–226

    Article  PubMed  Google Scholar 

  44. Traverse-Glehen A, Pittaluga S, Gaulard P et al (2005) Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B‑cell lymphoma. Am J Surg Pathol 29:1411–1421

    Article  PubMed  Google Scholar 

  45. https://tumourclassification.iarc.who.int

  46. Vrzalikova K, Sunmonu T, Reynolds G et al (2018) Contribution of Epstein(-)Barr virus latent proteins to the pathogenesis of classical Hodgkin lymphoma. Pathogens 7(3):59. https://doi.org/10.3390/pathogens7030059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Xia D, Sayed S, Moloo Z et al (2022) Geographic variability of nodular lymphocyte-predominant Hodgkin lymphoma. Am J Clin Pathol 157:231–243

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. Senckenbergisches Institut für Pathologie, Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    Sylvia Hartmann

  2. Institut für Pathologie und Neuropathologie, Eberhard Karls Universität Tübingen, Tübingen, Deutschland

    Falko Fend

Authors
  1. Sylvia Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Falko Fend
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvia Hartmann.

Ethics declarations

Interessenkonflikt

S. Hartmann und F. Fend geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Schwerpunktherausgeber

Falko Fend, Tübingen

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hartmann, S., Fend, F. Klassifikation der Hodgkin-Lymphome und verwandter Entitäten. Pathologie 44, 184–192 (2023). https://doi.org/10.1007/s00292-023-01188-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-023-01188-3

Schlüsselwörter

Keywords

Search

Navigation